Plain Language Summary

What is it about?

Healthcare decision makers traditionally use quality-adjusted life-years to measure treatment value, but these fail to account for risk preferences and may undervalue treatments for severely ill patients. Generalized risk-adjusted cost-effectiveness addresses these problems but requires specific health measurements often unavailable to researchers. This study develops a simple method to convert commonly available time trade-off utilities into risk-adjusted values without collecting new data, filling a critical gap that previously hindered practical implementation.

How was the research conducted?

The researchers created a statistical bridge between 2 health measurement types using Medical Expenditure Panel Survey data from over 19,000 Americans. They tested different mathematical formulas using nonlinear least squares regression to find which best predicted visual analog scale health from time trade-off scores. This method was chosen because it identified the most accurate relationship using real-world population data.

What were the results?

A simple linear formula provides the best conversion: visual analog scale health equals 0.19 plus 0.70 times the time trade-off score. Incorporating this relationship into the GRACE utilities allows one to compute them directly using time trade-off scores.  Doing so reveals that traditional time trade-off scores work reasonably well for moderate health states but become increasingly inaccurate for severe health states. Surprisingly, traditional methods substantially underestimate health improvement value for the sickest patients.

Why are the results important?

These results enable more accurate value assessments without collecting expensive additional data, potentially improving coverage decisions for therapies targeting severely ill populations. Researchers gain practical tools, severely ill patients may see improved treatment access, and payers can make decisions complying with antidiscrimination laws. Long-term impacts include more equitable healthcare resource allocation and better alignment between patient preferences and coverage decisions.

What are the strengths and weaknesses of this study?

The main strength is providing a simple solution enabling immediate implementation of improved value assessment using existing data. The main limitation is combining 2 separate data sources rather than measuring all variables in the same individuals. Future research could validate these mappings by collecting all measurements simultaneously and extending this approach to other health measurement systems.

^{Note: This content was created with assistance from artificial intelligence (AI) and has been reviewed and edited by ISPOR staff. For more information or for inquiries on ISPOR’s AI policy, click here or contact us at info@ispor.org.}